The Registry of Toxic Effects of Chemical Substances

Sodium azide

RTECS #: VY8050000

CAS #: 26628-22-8

UPDATE: February 2005 MW: 65.02 MF: N3Na


NOTE:

TABLE OF CONTENTS:
  1. SYNONYMS:
  2. MUTATION DATA:
  3. TUMORIGENIC DATA:
  4. ACUTE TOXICITY DATA:
  5. OTHER MULTIPLE DOSE DATA:
  6. REVIEWS:
  7. STANDARDS AND REGULATIONS:
  8. NIOSH DOCUMENTATION AND SURVEILLANCE:
  9. STATUS IN FEDERAL AGENCIES:
  10. REFERENCES:

SYNONYMS:

  1. Azide, sodium
  2. Azoture de sodium (French)
  3. Azydek sodu (Polish)
  4. NSC 3072
  5. Kazoe
  6. Natriumazid (German)
  7. Natriummazide (Dutch)
  8. NCI - C06462
  1. Nemazyd
  2. RCRA waste number P105
  3. Sodium azide (ACGIH)
  4. Sodium, azoture de (French)
  5. Sodium, azoturo di (Italian)
  6. Smite
  7. U - 3886


SKIN AND EYE IRRITATION DATA AND REFERENCES:

ROUTE/
ORGANISM 		DOSE
EFFECT

 REFERENCE
N/R
 N/R N/R N/R


MUTATION DATA AND REFERENCES:

SYSTEM TEST ROUTE/
ORGANISM/
TISSUE 		DOSE REFERENCE
dominant lethal test oral
other insects 		100 mg/L EXPEAM 37,824,1981
DNA damage human leukocyte 3 mmol/L MUREAV 468,93,2000
DNA inhibition human HeLa cell 30 mmol/L CRNGDP 13,2389,1992
DNA inhibition human fibroblast 50 mg/L STBIBN 78,165,1980
DNA repair Escherichia coli 5 gm/L MUREAV 119,135,1983
mutation in microorganisms Escherichia coli 150 nmol/L (-enzymatic activation step) ENMUDM 3,11,1981
mutation in microorganisms Escherichia coli 33,300 ng/plate (+enzymatic activation step) ENMUDM 6(Suppl 2),1,1984
mutation in microorganisms Escherichia coli 10 µg/well/12 hour MUREAV 520,161,2002
mutation in microorganisms Euglena gracilis 5 mg/L (-enzymatic activation step) TCMUD8 5,329,1985
mutation in microorganisms other microorganisms 600 ppm (-enzymatic activation step) POASAD 34,114,1953
mutation in microorganisms Salmonella typhimurium 30 ng/plate (+enzymatic activation step) ENMUDM 9(Suppl 9),1,1987
mutation in microorganisms Salmonella typhimurium 1.5 µg/plate/44 hour FCTOD7 40,105,2002
mutation in microorganisms Salmonella typhimurium 1 µg/plate/3 hour (-enzymatic activation step) FCTOD7 40,1,2002
mutation in microorganisms Salmonella typhimurium 1 µg/plate/20 minute (-enzymatic activation step) MUREAV 494,41,2001
mutation in microorganisms Salmonella typhimurium 0.5 µg/plate/90 minute (-enzymatic activation step) MUREAV 490,45,2001
mutation in microorganisms Salmonella typhimurium 0.5 µg/plate/72 hour (-enzymatic activation step) MUTAEX 16,303,2001
mutation in microorganisms Salmonella typhimurium 1 µg/plate/20 minute (+enzymatic activation step) EMMUEG 37,324,2001
mutation in microorganisms Salmonella typhimurium 1.5 µg/plate/24 hour (+/-enzymatic activation step) BECTA6 65,691,2000
mutation in microorganisms Salmonella typhimurium 1.5 µL/plate (-enzymatic activation step) VHTODE 42,77,2000
mutation in microorganisms Salmonella typhimurium 10 mg/L/48 hour MUREAV 520,161,2002
mutation in microorganisms Salmonella typhimurium 1.5 µg/plate/2 day (+/-enzymatic activation step) BECTA6 65,691,2000
mutation in microorganisms Salmonella typhimurium 20 mg/L/72 hour (-enzymatic activation step) EMMUEG 36,52,2000
mutation in microorganisms Salmonella typhimurium 0.1 mg/plate/3 day MUREAV 521,19,2002
mutation in microorganisms Salmonella typhimurium 0.25 mg/plate/45 minute (-enzymatic activation step) TCMUD8 22,285,2002
mutation in microorganisms Salmonella typhimurium 1.25 µg/plate/2 day (-enzymatic activation step) MUREAV 537,201,2003
mutation in microorganisms Salmonella typhimurium mammary gland 5 µg/plate/48 hour (-enzymatic activation step) EMMUEG 41,43,2003
mutation in microorganisms Salmonella typhimurium 0.5 µg/plate (-enzymatic activation step) FCTOD7 40,599,2002
mutation in microorganisms Salmonella typhimurium 1 µg/plate/48 hour (-enzymatic activation step) MUREAV 557,85,2004
mutation in microorganisms Salmonella typhimurium 0.2 µmol/plate/72 hour (-enzymatic activation step) MUREAV 558,93,2004
mutation in microorganisms Salmonella typhimurium 2.5 µg/plate/48 hour TCMUD8 23,85,2003
mutation in microorganisms Salmonella typhimurium 1 µg/plate/24 hour (-enzymatic activation step) TCMUD8 23,137,2003
mutation in microorganisms Salmonella typhimurium embryo 0.5 µg/plate/72 hour (-enzymatic activation step) MUREAV 561,101,2004
mutation in mammalian somatic cells hamster lung 1 mmol/L MUREAV 77,293,1980
mutation in mammalian somatic cells mouse lymphocyte 500 mg/L/2 hour MUREAV 59,61,1979
mutation in mammalian somatic cells rat liver 1 mmol/L MUREAV 77,293,1980
phage inhibition capacity Escherichia coli 1,100 ng/well MUREAV 260,349,1991
specific locus test oral
Drosophila melanogaster 		500 µmol/L MUREAV 389,157,1997
heritable translocation test oral
other insects 		100 mg/L EXPEAM 37,824,1981


REPRODUCTIVE EFFECTS DATA AND REFERENCES:

ROUTE/
ORGANISM 		DOSE
EFFECT

 REFERENCE
N/R
 N/R N/R N/R


TUMORIGENIC DATA AND REFERENCES:

ROUTE/
ORGANISM 		DOSE
EFFECT

 REFERENCE
oral
rat 		lowest published toxic dose: 2,730 mg/kg/78 week- continuous Tumorigenic: Equivocal tumorigenic agent by RTECS criteria

Endocrine: Tumors

Skin and Appendages: Tumors 		JJIND8 67,75,1981
oral
rat 		toxic dose : 5,460 mg/kg/78 week- continuous Tumorigenic: Equivocal tumorigenic agent by RTECS criteria

Endocrine: Tumors

Skin and Appendages: Tumors 		JJIND8 67,75,1981


ACUTE TOXICITY DATA AND REFERENCES:

ROUTE/
ORGANISM 		DOSE
EFFECT

 REFERENCE
inhalation
mouse 		lethal concentration (50 percent kill): 32,400 µg/m3 Eye: Other eye effects

Behavioral: Convulsions or effect on seizure threshold

Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi 		STGNBT -,173,1999
inhalation
rat 		lethal concentration (50 percent kill): 37 mg/m3 Eye: Other eye effects

Behavioral: Convulsions or effect on seizure threshold

Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi 		STGNBT -,173,1999
intraperitoneal
mouse 		lethal dose (50 percent kill): 28 mg/kg Behavioral: Convulsions or effect on seizure threshold

Behavioral: Change in motor activity (specific assay)

Lung, Thorax, or Respiration: Respiratory stimulation 		JIHTAB 30,98,1948
intraperitoneal
rat 		lowest published lethal dose: 30 mg/kg N/R PHRPA6 58,607,1943
intraperitoneal
rat 		lowest published lethal dose: 3 mg/kg Behavioral: Coma

Lung, Thorax, or Respiration: Respiratory depression

Nutritional and Gross Metabolic: Body temperature decrease 		VCVN5* -,25,1993
intratracheal
rat 		lethal dose (50 percent kill): 47,500 µg/kg Peripheral Nerve and Sensation: Spastic paralysis with/without sensory change

Lung, Thorax, or Respiration: Other changes 		MEPAAX 12,427,1961
intratracheal
rat 		lethal dose (50 percent kill): 47.5 mg/kg N/R VCVN5* -,26,1993
intravenous
monkey 		lowest published lethal dose: 12 mg/kg Eye: Mydriasis (pupilliary dilation)

Behavioral: Convulsions or effect on seizure threshold

Vascular: BP lowering not characterized in autonomic section 		BRAIAK 95,505,1972
intravenous
mouse 		lethal dose (50 percent kill): 19 mg/kg N/R CLDND*
oral
wild bird 		lethal dose (50 percent kill): 23,700 µg/kg N/R AECTCV 12,355,1983
oral
human 		lowest published toxic dose: 710 µg/kg Behavioral: General anesthetic

Behavioral: Somnolence (general depressed activity)

Kidney, Ureter, and Bladder: Other changes 		JCPAAK 28,350,1975
oral
man 		lowest published lethal dose: 29 mg/kg Brain and Coverings: Increased intracranial pressure

Cardiac: Pulse rate decreased with fall in BP

Lung, Thorax, or Respiration: Acute pulmonary edema 		MTAEEB 4,219,1989
oral
man 		lowest published lethal dose: 129 mg/kg Behavioral: Coma

Cardiac: Pulse rate decreased with fall in BP

Cardiac: Other changes 		JATOD3 20,134,1996
oral
man 		lowest published lethal dose: 143 mg/kg Eye: Mydriasis (pupilliary dilation)

Behavioral: Somnolence (general depressed activity)

Behavioral: Irritability 		JTCTDW 24,339,1986
oral
man 		lowest published toxic dose: 129 µg/kg Cardiac: Pulse rate increased without fall in BP

Vascular: BP lowering not characterized in autonomic section

Blood: Changes in spleen 		YAKUD5 40,1407,1998
oral
man 		lowest published toxic dose: 1,143 µg/kg Cardiac: Cardiomyopathy including infarction

Lung, Thorax, or Respiration: Other changes

Musculoskeletal: Other changes 		BJIMAG 39,308,1982
oral
mouse 		lethal dose (50 percent kill): 27 mg/kg N/R CLDND*
oral
rat 		lethal dose (50 percent kill): 27 mg/kg N/R FMCHA2 -,C32,1991
oral
woman 		lowest published lethal dose: 786 mg/kg Behavioral: Convulsions or effect on seizure threshold

Behavioral: Coma

Cardiac: Arrythmias (indlucing changes in conduction) 		MTAEEB 4,219,1989
oral
woman 		lowest published lethal dose: 14 mg/kg Behavioral: Convulsions or effect on seizure threshold

Cardiac: Arrythmias (indlucing changes in conduction)

Cardiac: Change in force of contraction 		JFSCAS 35,193,1990
oral
woman 		lowest published toxic dose: 3 mg/kg Behavioral: Headache

Lung, Thorax, or Respiration: Dyspnea

Gastrointestinal: Hypermotility, diarrhea 		ATXKA8 20,279,1965
subcutaneous
mouse 		lethal dose (50 percent kill): 23,060 µg/kg Peripheral Nerve and Sensation: Spastic paralysis with/without sensory change

Lung, Thorax, or Respiration: Other changes 		MEPAAX 12,427,1961
subcutaneous
mouse 		lethal dose (50 percent kill): 23 mg/kg N/R VCVN5* -,26,1993
subcutaneous
rat 		lethal dose (50 percent kill): 45,100 µg/kg Peripheral Nerve and Sensation: Spastic paralysis with/without sensory change

Lung, Thorax, or Respiration: Other changes 		MEPAAX 12,427,1961
subcutaneous
rat 		lethal dose (50 percent kill): 45 mg/kg N/R VCVN5* -,26,1993
subcutaneous
rabbit 		lowest published lethal dose: 17 mg/kg N/R ATXKA8 22,160,1966
skin
rat 		lethal dose (50 percent kill): 50 mg/kg N/R STGNBT -,173,1999
skin
rabbit 		lethal dose (50 percent kill): 20 mg/kg N/R FMCHA2 -,C32,1991
unreported route
mouse 		lethal dose (50 percent kill): 27 mg/kg N/R BJCAAI 6,160,1952


OTHER MULTIPLE DOSE DATA AND REFERENCES:

ROUTE/
ORGANISM 		DOSE
EFFECT

 REFERENCE
intraperitoneal
rat 		lowest published toxic dose: 15 mg/kg/5 day- intermittent Lung, Thorax, or Respiration: Respiratory depression

Nutritional and Gross Metabolic: Body temperature decrease

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field 		VCVN5* -,25,1989
oral
mammal (species unspecified) 		lowest published toxic dose: 240 mg/kg/30 day- intermittent Cardiac: EKG changes not diagnostic of above

Vascular: BP lowering not characterized in autonomic section

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase 		STGNBT -,173,1999
oral
mammal (species unspecified) 		lowest published toxic dose: 45,500 µg/kg/26 week- intermittent Cardiac: EKG changes not diagnostic of above

Liver: Liver function tests impaired

Kidney, Ureter, and Bladder: Other changes in urine composition 		STGNBT -,173,1999
oral
mouse 		lowest published toxic dose: 81,250 µg/kg/13 week- intermittent Liver: Changes in liver weight TOXID9 5,195,1985
oral
rat 		lowest published toxic dose: 5,206 mg/kg/39 day- continuous Nutritional and Gross Metabolic: Weight loss or decreased weight gain

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field 		PHRPA6 58,607,1943
oral
rat 		lowest published toxic dose: 81,250 µg/kg/13 week- intermittent Liver: Changes in liver weight NTPTR* NTP-TR-389,1991
oral
rat 		lowest published toxic dose: 240 mg/kg/14 day- intermittent Cardiac: Changes in heart weight

Liver: Changes in liver weight

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field 		NTPTR* NTP-TR-389,1991
oral
rat 		lowest published toxic dose: 5,150 mg/kg/103 week- intermittent Blood: Leukemia

Endocrine: Adrenal cortex tumors

Tumorigenic: Active as anti-cancer agent 		NTIS** PB92-135615
oral
rat 		lowest published toxic dose: 2,575 mg/kg/103 week- intermittent Skin and Appendages: Tumors

Tumorigenic: Active as anti-cancer agent 		NTIS** PB92-135615
subcutaneous
rat 		lowest published toxic dose: 740 mg/kg/74 day- intermittent Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field MEPAAX 12,427,1961


REVIEWS:

ORGANIZATION STANDARD
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value Not Classifiable as a Human Carcinogen DTLVS* TLV/BEI,2003
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value ceiling concentration 0.11 ppm DTLVS* TLV/BEI,2003
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value ceiling concentration 0.29 mg/m3 DTLVS* TLV/BEI,2003
TOXICOLOGY REVIEW
FNSCA6 2,67,1973


STANDARDS AND REGULATIONS:

ORGANIZATION STANDARD
REFERENCE
Occupational Exposure Limit - AUSTRALIA time-weighted average 0.1 ppm (0.3 mg/m3), JAN1993
Occupational Exposure Limit - AUSTRIA MAK 0.07 ppm (0.2 mg/m3), JAN1999
Occupational Exposure Limit - BELGIUM short term exposure limit 0.11 ppm (0.3 mg/m3), JAN1993
Occupational Exposure Limit - DENMARK time-weighted average 0.3 mg/m3, JAN1999
Occupational Exposure Limit - FINLAND time-weighted average 0.1 ppm (0.3 mg/m3), short term exposure limit 0.3 ppm (0.9 mg/m3), JAN1999
Occupational Exposure Limit - FRANCE VLE 0.1 ppm (0.3 mg/m3), JAN1999
Occupational Exposure Limit - GERMANY MAK 0.07 ppm (0.2 mg/m3), JAN1999
Occupational Exposure Limit - THE NETHERLANDS MAC-TGG 0.1 mg/m3, Skin, 2003
Occupational Exposure Limit - SWITZERLAND MAK- week 0.07 ppm (0.2 mg/m3), JAN1999
Occupational Exposure Limit - UNITED KINGDOM short term exposure limit 0.3 mg(NaN3), SEP2000
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value;

ceiling concentration 0.29 mg/m3
Occupational Exposure Limit IN NEW ZEALAND, SINGAPORE, VIETNAM American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
ceiling concentration 0.29 mg/m3


NIOSH DOCUMENTATION AND SURVEILLANCE:

ORGANIZATION STANDARD or SURVEY
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO SODIUM AZIDE, as HN3-air ceiling concentration 0.1 ppm (Sk) NIOSH* DHHS #92-100,1992
National Occupational Hazard Survey 1974 National Occupational Hazard Survey 1974: Hazard Code: 68820;
Number of Industries 13;
Total Number of Facilities 877;
Number of Occupations 10;
Total Number of Employees Exposed 5,953
National Occupational Exposure Survey 1983 National Occupational Exposure Survey 1983: Hazard Code: 68820;
Number of Industries 19;
Total Number of Facilities 3,640;
Number of Occupations 27;
Total Number of Employees Exposed 54,959;
Total Number of Female Employees Exposed 38,370


STATUS IN FEDERAL AGENCIES:

ORGANIZATION
REFERENCE
EPA GENETOX PROGRAM 1988, Positive: L5178Y cells in vitro-TK test
EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal
EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion
EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-forward mutation; S cerevisiae-reversion
EPA GENETOX PROGRAM 1988, Negative: In vitro cytogenetics-human lymphocyte
EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse; In vitro UDS-human fibroblast
EPA GENETOX PROGRAM 1988, Negative: TRP reversion
EPA GENETOX PROGRAM 1988, Inconclusive: Carcinogenicity-mouse/rat; TRP reversion
EPA TSCA Section 8(b) CHEMICAL INVENTORY
Used in preparation of LEAD AZIDE for explosives and as preservative and diluent
EPA TSCA Section 8(d) unpublished health/safety studies
On EPA IRIS database
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
NIOSH CURRENT INTELLIGENCE BULLETIN 13, 1976
NCI Carcinogenesis Studies (gavage);no evidence:rat
OSHA ANALYTICAL METHOD #ID211


REFERENCES:

CODEN
REFERENCE
AECTCV Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973-
ATXKA8 Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN.
BECTA6 Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966-
BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947-
BJIMAG British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944-
BRAIAK Brain; Journal of Neurology. (Oxford Univ. Press, Walton St., Oxford OX2 6DP, UK) V.1- 1878-
CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980-
DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
EMMUEG Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987-
ENMUDM Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG.
EXPEAM Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945-
FCTOD7 Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982-
FMCHA2 Farm Chemicals Handbook. (Meister Pub., 37841 Euclid Ave., Willoughy, OH 44094)
FNSCA6 Forensic Science. (Lausanne, Switzerland) V.1-11, 1972-78. For pub lisher information, see FSINDR.
JATOD3 Journal of Analytical Toxicology. (Preston Pub. Inc., POB 48312, Niles, IL 60648) V.1- 1977-
JCPAAK Journal of Clinical Pathology. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1947-
JFSCAS Journal of Forensic Sciences. (American Soc. for Testing and Materials, 1916 Race St., Philadelphia, PA 19103) V.1- 1956-
JIHTAB Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU.
JJIND8 JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ.
JTCTDW Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982-
MEPAAX Medycyna Pracy. Industrial Medicine. (Ars-Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1950-
MTAEEB Medical Toxicology and Adverse Drug Experience. (Adis International Ltd., Private Baq 65901, Mairangi Bay, Auckland 10, N.Z.) V.4- 1989-
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964-
MUTAEX Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986-
NIOSH* National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda.
NTIS** National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific & Technical Information.
NTPTR* National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206-
PHRPA6 Public Health Reports. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1878-
POASAD Proceedings of the Oklahoma Academy of Science. (Oklahoma Academy of Science, c/o Executive Secretary-Treasurer, Southwestern Oklahoma State Univ., Weatherford, OK 73096) V.1- 1910/1920-
STBIBN Studia Biophysica. (Akademie-Verlag GmbH, Postfach 1233, Berlin DDR-1086, Ger. Dem. Rep.) V.1- 1966-
STGNBT "Spravochnik po Toksikologii i Gigienicheskim Normativam (PDK) Potentsial'no Opasnykh Khimicheskikh Veshchestv" Kushneva, V.S., and R.B. Gorshkova, eds. 46, Zhivopisnaya St., 123182, Moscow, Russia, IzdAT 1999
TCMUD8 Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980-
TOXID9 Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981-
VCVN5* "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989.
VHTODE Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977-
YAKUD5 Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959-

Used in preparation of LEAD AZIDE for explosives and as preservative and diluent

NIOSH PROFILE (AZIDES, INORGANIC), SRC, 10/81

NIOSH PROFILE (SODIUM AZIDE), SRI, 2/77

RTECS Compound Description:
   Agricultural Chemical
   Tumorigen
   Drug
   Mutagen
   Human Data

ALT CAS #: 12136-89-9
 Click Here for Additional Information about RTECS